These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32223985)

  • 1. Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky.
    Cooper HL; Cloud DH; Freeman PR; Fadanelli M; Green T; Van Meter C; Beane S; Ibragimov U; Young AM
    Int J Drug Policy; 2020 Nov; 85():102701. PubMed ID: 32223985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists.
    Hill LG; Light AE; Green TC; Burns AL; Sanaty Zadeh P; Freeman PR
    J Am Pharm Assoc (2003); 2023; 63(1):252-260.e6. PubMed ID: 36202711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.
    Ostrach B; Potter R; Wilson CG; Carpenter D
    J Am Pharm Assoc (2003); 2022; 62(2):588-597.e2. PubMed ID: 34674965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors in rural community buprenorphine dispensing.
    Major EG; Wilson CG; Carpenter DM; Harless JC; Marley GT; Ostrach B
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100204. PubMed ID: 36703716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing buprenorphine bottlenecks in the context of MAT Act implementation: A shared responsibility.
    Ostrach B; Hill L; Carpenter D; Pollini R
    J Am Pharm Assoc (2003); 2023; 63(4):1044-1048. PubMed ID: 37149144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.
    Smith KE; Tillson MD; Staton M; Winston EM
    Drug Alcohol Depend; 2020 Mar; 208():107837. PubMed ID: 31951906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEA Disconnect Leads to Buprenorphine Bottlenecks.
    Ostrach B; Carpenter D; Cote LP
    J Addict Med; 2021 Jul-Aug 01; 15(4):272-275. PubMed ID: 33181577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky.
    Fadanelli M; Cloud DH; Ibragimov U; Ballard AM; Prood N; Young AM; Cooper HLF
    Int J Drug Policy; 2020 Nov; 85():102588. PubMed ID: 31753603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies.
    Freeman PR; Hammerslag LR; Ahrens KA; Sharbaugh M; Gordon AJ; Austin AE; Donohue JM; Allen LD; Barnes AJ; Talbert JC
    JAMA Health Forum; 2024 May; 5(5):e241077. PubMed ID: 38758569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky.
    Shrestha S; Lindstrom MR; Harris D; Rock P; Srinivasan S; Pustz JC; Bayly R; Stopka TJ
    J Subst Use Addict Treat; 2023 Jul; 150():209077. PubMed ID: 37211155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia.
    Trull G; Major E; Harless C; Zule W; Ostrach B; Carpenter D
    Explor Res Clin Soc Pharm; 2021 Dec; 4():100082. PubMed ID: 35479845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Red Flags' and 'Red Tape': Telehealth and pharmacy-level barriers to buprenorphine in the United States.
    Textor L; Ventricelli D; Aronowitz SV
    Int J Drug Policy; 2022 Jul; 105():103703. PubMed ID: 35561484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to utilize a mobile treatment unit in five counties at the epicenter of the US rural opioid epidemic.
    Peddireddy SR; Livingston MD; Young AM; Freeman PR; Ibragimov U; Komro KA; Lofwall MR; Oser CB; Staton M; Cooper HLF
    J Subst Use Addict Treat; 2024 Apr; 159():209262. PubMed ID: 38103835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.
    Brown JD; Goodin AJ; Talbert JC
    J Rural Health; 2018 Dec; 34(1):6-13. PubMed ID: 28685864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community Pharmacists' Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder.
    Tutag Lehr V; Nolan C
    J Addict Med; 2023 Jul-Aug 01; 17(4):e224-e231. PubMed ID: 37579094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.
    Patrick SW; Buntin MB; Martin PR; Scott TA; Dupont W; Richards M; Cooper WO
    Subst Abus; 2019; 40(3):356-362. PubMed ID: 29949454
    [No Abstract]   [Full Text] [Related]  

  • 17. Rural risk environments for hepatitis c among young adults in appalachian kentucky.
    Cloud DH; Ibragimov U; Prood N; Young AM; Cooper HLF
    Int J Drug Policy; 2019 Oct; 72():47-54. PubMed ID: 31113713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
    Andrilla CHA; Moore TE; Patterson DG
    J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Now We Are Seeing the Tides Wash In": Trauma and the Opioid Epidemic in Rural Appalachian Ohio.
    Schalkoff CA; Richard EL; Piscalko HM; Sibley AL; Brook DL; Lancaster KE; Miller WC; Go VF
    Subst Use Misuse; 2021; 56(5):650-659. PubMed ID: 33678117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.